Menu
Back to Journals » Cancer Management and Research » Volume 10
Review
Evolution of regorafenib from bench to bedside in colorectal cancer: Is it an attractive option or merely a “me too” drug?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 19,452 | Dovepress* | 16,171+ | 1,770 | 17,941 | |
| PubMed Central* | 3,281 | 685 | 3,966 | ||
| Totals | 19,452 | 2,455 | 21,907 | ||
| *Since 6 March 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 2 | 6 |
View citations on PubMed Central and Google Scholar